Literature DB >> 7958498

Active and passive mechanical properties of isolated arterioles from STZ-induced diabetic rats. Effect of aminoguanidine treatment.

M A Hill1, E A Ege.   

Abstract

Studies were performed to examine the effect of experimental diabetes (4-6 weeks duration) on both the passive elastic and active myogenic properties of isolated skeletal muscle arterioles. Studies were conducted on untreated streptozotocin (60 mg/kg)-induced diabetic rats and in similar rats treated daily with either amino-guanidine (25 mg/kg) or methylguanidine (25 mg/kg). First-order cremaster muscle arterioles were isolated, cannulated, and pressurized in the absence of intraluminal flow. Video microscopy was used to determine relationships between arteriolar diameter and intraluminal pressure both in the active and passive (o mmol/l Ca(2+)-2 mmol/l EGTA superfusated) tes. The measurements were used to calculate active myogenic responses, arteriolar distensibility, and stress-strain relationships. Under passive conditions, arterioles from untreated diabetic animals appeared to be stiffer and less distensible compared with similar arterioles from control animals. Under active conditions, i.e., in the presence of extracellular Ca2+, arterioles from the untreated diabetic group showed impaired myogenic reactivity as evidenced by a significant (P < 0.001) reduction in the negative slope of the pressure-diameter relationship over a physiological range of intraluminal pressures. Chronic treatment with aminoguanidine prevented the diabetes-induced changes in the active and passive properties of the isolated arterioles while treatment with methylguanidine appeared ineffective. Vasodilator responses to topically applied acetylcholine (10(-8) to 5 x 10(-6) mol/l) were significantly impaired in diabetic animals irrespective of treatment with aminoguanidine. The data indicate that experimental diabetes is associated with a decreased passive distensibility, or stiffening, of skeletal muscle arterioles that, in addition, may contribute to impaired active myogenic responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7958498     DOI: 10.2337/diab.43.12.1450

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  14 in total

Review 1.  Endothelial dysfunction in diabetes: multiple targets for treatment.

Authors:  Hong Ding; Chris R Triggle
Journal:  Pflugers Arch       Date:  2010-03-18       Impact factor: 3.657

2.  Reduced stiffness and augmented traction force in type 2 diabetic coronary microvascular smooth muscle.

Authors:  Patricia E McCallinhart; Youjin Cho; Zhe Sun; Samir Ghadiali; Gerald A Meininger; Aaron J Trask
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-05-01       Impact factor: 4.733

3.  Assessing Myogenic Response and Vasoactivity In Resistance Mesenteric Arteries Using Pressure Myography.

Authors:  Ravirajsinh N Jadeja; Vikrant Rachakonda; Zsolt Bagi; Sandeep Khurana
Journal:  J Vis Exp       Date:  2015-07-06       Impact factor: 1.355

4.  Impact of experimental diabetes on the maternal uterine vascular remodeling during rat pregnancy.

Authors:  Julie K Phillips; Amanda M Vance; Renju S Raj; Maurizio Mandalà; Erika A Linder; Natalia I Gokina
Journal:  Reprod Sci       Date:  2012-03       Impact factor: 3.060

5.  Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products.

Authors:  J R Rumble; M E Cooper; T Soulis; A Cox; L Wu; S Youssef; M Jasik; G Jerums; R E Gilbert
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

6.  Annexin-A1 deficiency exacerbates pathological remodelling of the mesenteric vasculature in insulin-resistant, but not insulin-deficient, mice.

Authors:  Maria Jelinic; Nicola Kahlberg; Chen Huei Leo; Hooi Hooi Ng; Sarah Rosli; Minh Deo; Mandy Li; Siobhan Finlayson; Jesse Walsh; Laura J Parry; Rebecca H Ritchie; Cheng Xue Qin
Journal:  Br J Pharmacol       Date:  2020-02-11       Impact factor: 8.739

7.  Experimental nonenzymatic glycosylation of vitreous collagens occurs by two pathways.

Authors:  J S Pulido
Journal:  Trans Am Ophthalmol Soc       Date:  1996

Review 8.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

9.  Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.

Authors:  Kuo-Chu Chang; Kwan-Lih Hsu; Chuen-Den Tseng; Yue-Der Lin; Yi-Li Cho; Yung-Zu Tseng
Journal:  Br J Pharmacol       Date:  2006-04       Impact factor: 8.739

10.  N(epsilon)-(Carboxymethyl)lysine and Coronary Atherosclerosis-Associated Low Density Lipoprotein Abnormalities in Type 2 Diabetes: Current Status.

Authors:  Khaled A Ahmed; Sekaran Muniandy; Ikram S Ismail
Journal:  J Clin Biochem Nutr       Date:  2008-12-27       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.